Thorne Healthtech Stock Current Valuation
| THRNDelisted Stock | USD 6.40 0.48 8.11% |
Valuation analysis of Thorne HealthTech helps investors to measure Thorne HealthTech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Thorne HealthTech's price fluctuation is very steady at this time. Calculation of the real value of Thorne HealthTech is based on 3 months time horizon. Increasing Thorne HealthTech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Thorne HealthTech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Thorne Stock. However, Thorne HealthTech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.4 | Real 5.0 | Hype 6.4 | Naive 6.9 |
The intrinsic value of Thorne HealthTech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Thorne HealthTech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Thorne HealthTech helps investors to forecast how Thorne stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Thorne HealthTech more accurately as focusing exclusively on Thorne HealthTech's fundamentals will not take into account other important factors: Thorne HealthTech Company Current Valuation Analysis
Thorne HealthTech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Thorne HealthTech has a Current Valuation of 0.0. This is 100.0% lower than that of the Food Products sector and 100.0% lower than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Thorne Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Thorne HealthTech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Thorne HealthTech could also be used in its relative valuation, which is a method of valuing Thorne HealthTech by comparing valuation metrics of similar companies.Thorne HealthTech is currently under evaluation in current valuation category among its peers.
Thorne Fundamentals
| Price To Earning | 100.20 X | |||
| Revenue | 228.73 M | |||
| EBITDA | 10.31 M | |||
| Net Income | 14.93 M | |||
| Cash And Equivalents | 27.81 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 47.03 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 2.91 X | |||
| Book Value Per Share | 2.46 X | |||
| Cash Flow From Operations | 5.22 M | |||
| Earnings Per Share | 0.15 X | |||
| Price To Earnings To Growth | 0.09 X | |||
| Target Price | 6.9 | |||
| Number Of Employees | 544 | |||
| Market Capitalization | 259.95 M | |||
| Total Asset | 229.8 M | |||
| Retained Earnings | (116.48 M) | |||
| Working Capital | 77.06 M | |||
| Z Score | 4.15 | |||
| Net Asset | 229.8 M |
About Thorne HealthTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Thorne HealthTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Thorne HealthTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Thorne HealthTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Thorne HealthTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.Moving together with Thorne Stock
The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Thorne Stock
If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |